Advertisement

Topics

venBio Encourages Stockholders to Vote for Change

13:51 EST 2 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
venBio Responds to Misleading Comments from Immunomedics Reminds Immunomedics Stockholders to Take Advantage of Last Chance to Make Their Voices Heard Vote on the GOLD Proxy Card to Elect venBio’s Four...

Other Sources for this Article

Investors
Okapi Partners LLC
Bruce H. Goldfarb / Lydia Mulyk
212-297-0720 or Toll-free 855-305-0857
info@okapipartners.com
or
Media
Sloane & Company
Dan Zacchei, 212-486-9500
dzacchei@sloanepr.com
or
Joe Germani, 212-486-9500
jgermani@sloanepr.com

NEXT ARTICLE

More From BioPortfolio on "venBio Encourages Stockholders to Vote for Change"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...